Pages that link to "Q68532158"

The following pages link to Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III (Q68532158):

Displaying 43 items.

• Multiple isoforms of heparan sulfate D-glucosaminyl 3-O-sulfotransferase. Isolation, characterization, and expression of human cdnas and identification of distinct genomic loci (Q22001455) (← links)
• Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? (Q24561731) (← links)
• Heparan sulfate and heparin interactions with proteins (Q26796383) (← links)
• Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase (Q28114813) (← links)
• Mice deficient in heparan sulfate 3-O-sulfotransferase-1: Normal hemostasis with unexpected perinatal phenotypes (Q29041315) (← links)
• Synthesis of thrombin-inhibiting heparin mimetics without side effects (Q30573078) (← links)
• Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (Q33399576) (← links)
• Heparan sulfate 3-O-sulfation: a rare modification in search of a function. (Q33690545) (← links)
• Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence (Q33926104) (← links)
• The effect of precursor structures on the action of glucosaminyl 3-O-sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate (Q33948367) (← links)
• Heparan sulfate: antithrombotic or not? (Q35096964) (← links)
• The proteoglycan bikunin has a defined sequence (Q35400682) (← links)
• The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation (Q37447881) (← links)
• Heparin sensing: blue-chip binding (Q37698254) (← links)
• Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase (Q37708991) (← links)
• Glycan Determinants of Heparin-Tau Interaction (Q38288698) (← links)
• Mechanism of acceleration of antithrombin-proteinase reactions by low affinity heparin. Role of the antithrombin binding pentasaccharide in heparin rate enhancement (Q38296443) (← links)
• Portable sulphotransferase domain determines sequence specificity of heparan sulphate 3-O-sulphotransferases. (Q38296721) (← links)
• Discovery of a heparan sulfate 3-O-sulfation specific peeling reaction (Q38302345) (← links)
• Identification of a hexasaccharide sequence able to inhibit thrombin and suitable for 'polymerisation'. (Q38321135) (← links)
• Synthetic oligosaccharides having various functional domains: potent and potentially safe heparin mimetics (Q38324833) (← links)
• New synthetic heparin mimetics able to inhibit thrombin and factor Xa. (Q38324837) (← links)
• Introducing a C-interglycosidic bond in a biologically active pentasaccharide hardly affects its biological properties (Q38331679) (← links)
• Synthesis of a 3-deoxy-L-iduronic acid containing heparin pentasaccharide to probe the conformation of the antithrombin III binding sequence (Q38332253) (← links)
• Characterization and hormonal modulation of anticoagulant heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells (Q38353168) (← links)
• Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants (Q39070810) (← links)
• Sulfation patterns determine cellular internalization of heparin-like polysaccharides (Q39196713) (← links)
• Heparin and its derivatives modulate serine proteinases (SERPS) serine proteinase inhibitors (SERPINS) balance. Physiopathological relevance (Q40616897) (← links)
• Chemogenesis of an antiangiogenic glycosaminoglycan (Q40809250) (← links)
• Localization of anticoagulantly active heparan sulfate proteoglycans in vascular endothelium: antithrombin binding on cultured endothelial cells and perfused rat aorta (Q41197917) (← links)
• Interaction of heparin with synthetic antithrombin III peptide analogues (Q41763091) (← links)
• Control of growth factor networks by heparan sulfate proteoglycans (Q41962848) (← links)
• Effect of heparin on the glia-derived-nexin-thrombin interaction (Q42004743) (← links)
• More than a biomarker: the systemic consequences of heparan sulfate fragments released during endothelial surface layer degradation (2017 Grover Conference Series). (Q47143359) (← links)
• Determination of the anti-factor Xa activity of the synthetic pentasaccharide SR 90107A/ORG 31540 and of two structural analogues. (Q53363712) (← links)
• Inhibitory effect of chitin heparinoids on the lung metastasis of B16-BL6 melanoma. (Q54955117) (← links)
• Downstream Products are Potent Inhibitors of the Heparan Sulfate 2-O-Sulfotransferase (Q56395838) (← links)
• Anticoagulant potential of regioselective derivatized cellulose (Q74483891) (← links)
• Preparation and anticoagulant activity of the phosphosulfomannan PI-88 (Q78555917) (← links)
• Chemoenzymatic Synthesis of Classical and Non-classical Anticoagulant Heparan Sulfate Polysaccharides (Q79102031) (← links)
• Enhanced osteogenic activity of bone morphogenetic protein-2 by 2-O-desulfated heparin (Q82061689) (← links)
• Tissue Engineering at the Blood-Contacting Surface: A Review of Challenges and Strategies in Vascular Graft Development (Q88586250) (← links)
• Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers (Q92152542) (← links)